Arvaya Healthcare board meets on May 28 for FY26 results

1 min read     Updated on 21 May 2026, 07:45 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Arvaya Healthcare Limited will hold a board meeting on May 28, 2026, to approve the audited financial statements for the quarter and year ended March 31, 2026. The trading window for insiders remains closed until May 30, 2026.

powered bylight_fuzz_icon
40918511

*this image is generated using AI for illustrative purposes only.

Arvaya Healthcare Limited has announced that its board of directors will meet on Thursday, May 28, 2026. The meeting has been convened pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Agenda for the Meeting

The primary agenda for the upcoming board meeting is to consider and approve the audited financial results of the company. The directors will review both the standalone and consolidated financial statements for the fourth quarter and the financial year ended March 31, 2026. The approval will also include the auditors' report on these financial statements.

Trading Window Closure

In compliance with regulatory norms, the company has closed the trading window for dealing in its shares. This restriction applies to directors, promoters, designated persons, and their immediate relatives. The window closed on April 1, 2026, and will remain shut until May 30, 2026. The stock exchanges were previously intimated about this closure on March 26, 2026.

Key Details

Detail Information
Company Name Arvaya Healthcare Limited
Scrip Code 524723
Board Meeting Date May 28, 2026
Financial Period Q4 and FY Ended March 31, 2026
Trading Window Closure April 1, 2026 to May 30, 2026

How might Arvaya Healthcare Limited's FY2026 annual revenue and profitability figures compare to its previous fiscal year, and what growth trajectory does this signal for the company?

Will the board consider announcing a dividend or any capital allocation strategy alongside the approval of the FY2026 audited financial results?

How could the release of Arvaya Healthcare's Q4 and FY2026 results influence investor sentiment and the stock's performance once the trading window reopens on May 31, 2026?

like19
dislike

Bijoy Hans Limited Officially Renamed Arvaya Healthcare Limited with Effect from May 11, 2026

2 min read     Updated on 12 May 2026, 08:20 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Arvaya Healthcare Limited, formerly Bijoy Hans Limited, has officially changed its name effective May 11, 2026, following approval from the Registrar of Companies, Ministry of Corporate Affairs. The development was disclosed to BSE Limited on May 12, 2026, under Regulation 30 of the SEBI LODR Regulations, 2015. The Certificate of Incorporation was issued by the Central Processing Centre and the company's Memorandum and Articles of Association stand amended accordingly. The company is required to display its former name alongside the new name for two years as per Section 12 of the Companies Act.

powered bylight_fuzz_icon
40143000

*this image is generated using AI for illustrative purposes only.

Arvaya Healthcare Limited, formerly known as Bijoy Hans Limited, has formally completed its name change process following approval from the Registrar of Companies, Ministry of Corporate Affairs. The change became effective on May 11, 2026, and was disclosed to BSE Limited on May 12, 2026, under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Name Change Approval and Regulatory Disclosure

The company informed the Listing Department of BSE Limited that the Registrar of Companies, Ministry of Corporate Affairs, had approved the change in name from "Bijoy Hans Limited" to "Arvaya Healthcare Limited" with effect from May 11, 2026. This disclosure follows an earlier communication dated April 21, 2026, in which the company had informed the exchange of member approval for the name change, along with other agenda items. The Memorandum and Articles of Association of the company stand amended accordingly.

The key details of the name change are summarised below:

Parameter: Details
Former Name: Bijoy Hans Limited
New Name: Arvaya Healthcare Limited
Effective Date: May 11, 2026
CIN: L86100AS1985PLC002323
Disclosure Date: May 12, 2026
Regulatory Framework: Regulation 30, SEBI LODR Regulations, 2015
Approving Authority: Registrar of Companies, Ministry of Corporate Affairs

Certificate of Incorporation

The Certificate of Incorporation pursuant to the change of name was issued by the Central Processing Centre of the Ministry of Corporate Affairs, located at Plot No. 6, 7, 8, Sector 5, IMT Manesar, Manesar, Haryana, India, 122050. The certificate was digitally signed on May 11, 2026, by Sweety Kumar, Central Processing Centre, in accordance with rule 29 of the Companies (Incorporation) Rules, 2014, and rule 9(2) of the Companies (Registration Offices and Fees) Rules, 2014.

The certificate confirms that the company, originally incorporated as Bijoy Hans Limited, is a company limited by shares. The registered mailing address on record with the Registrar of Companies is Nirvana Co Working Spaces, Mezzanine Floor, Itag Plaza, ABC, G S Road, Guwahati, Dispur, Gmc, Kamrup- 781005, Assam, India.

Compliance Obligations

As per the Certificate of Incorporation, the name change does not affect the rights and liabilities of stakeholders. The company is obligated to display its former name alongside the new name for a period of two years at all places where it is required to display its name, in terms of Section 12 of the Companies Act. Stakeholders are advised to verify the latest status of the company and its directors on the Ministry of Corporate Affairs website at www.mca.gov.in/MCA21 .

The disclosure was signed by Kaushal Shah, Managing Director (DIN: 02175130), on behalf of Arvaya Healthcare Limited.

What specific healthcare business segments or acquisitions is Arvaya Healthcare Limited planning to pursue following its rebranding from Bijoy Hans Limited?

How might the strategic pivot to a healthcare-focused identity impact the company's stock performance and investor sentiment on BSE in the near term?

Will Arvaya Healthcare Limited seek additional capital raises or strategic partnerships to support its transition into the healthcare sector?

like16
dislike